Gary Bridger

Director, Neurogene Inc.

Companies

X4 Pharmaceuticals, IncBoard member Mar 14, 2019 to now¹
Neurogene Inc.Board member Mar 6, 2014 to May 9, 2018²
Xenon PharmaceuticalsEVP, Research & Development Nov 4, 2014 to Nov 25, 2014³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARX4 Pharmaceuticals, Inc, Board member
2
SEC EDGARNeurogene Inc., Board member
3
SEC EDGARXenon Pharmaceuticals, EVP, Research & Development